Fig. 2From: Adverse clinical outcomes associated with double dose clopidogrel compared to the other antiplatelet regimens in patients with coronary artery disease: a systematic review and meta-analysisComparing the adverse cardiovascular outcomes observed with double dose clopidogrel versus the other antiplatelet regimensBack to article page